The optimal neoadjuvant treatment strategy for HR+/HER2 + breast cancer: a network meta-analysis
HR+/HER2+乳腺癌的最佳新辅助治疗策略:一项网络荟萃分析
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-024-84039-2
Liu, Shiwei; Yu, Miao; Mou, Exian; Wang, Meihua; Liu, Shuanghua; Xia, Li; Li, Hui; Tang, Hao; Feng, Yajing; Yu, Xin; Mi, Kun; Wang, Hao